![]() |
市場調査レポート
商品コード
1417532
in vitro毒性試験市場レポート:2030年までの動向、予測、競合分析In-Vitro Toxicology Testing Market Report: Trends, Forecast and Competitive Analysis to 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
in vitro毒性試験市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
|
in vitro毒性試験の動向と予測
世界のin vitro毒性試験市場は、2024年から2030年までのCAGRが9.3%で、2030年までに推定188億米ドルに達すると予想されます。この市場の主な促進要因は、オーダーメイド医療や創薬のための試験管内技術への注目の高まり、動物実験に対する社会的反対の高まり、研究開発による早期毒性検出への取り組みなどです。世界の試験管内毒性試験市場の将来は、製薬産業、化粧品・家庭用品、学術機関・研究所、診断、化学産業、食品産業における機会で有望視されています。
in vitro毒性試験市場の洞察
Lucintelは、予測期間中も全身毒性学が最大セグメントであり続けると予測しています。
北米は、治療研究に対する政府資金の増加、ヘルスケア支出の増加、洗練されたインフラと創薬手順の研究開発、承認に向けた強固な規制環境のため、予測期間中も最大地域であり続けるでしょう。
Q1.市場規模は?
A1.世界のin vitro毒性試験市場は、2030年までに推定188億米ドルに達すると予想されています。
Q2.市場の成長予測は?
A2.世界のin vitro毒性試験市場は、2024年から2030年にかけてCAGR 9.3%で成長すると予想されます。
Q3.市場の成長に影響を与える主な促進要因は?
A3.この市場の主な促進要因は、オーダーメイド医療と創薬のためのin vitro技術への注目の高まり、動物実験に対する社会的反対の高まり、研究開発による早期毒性検出への取り組みです。
Q4.市場の主要セグメントは?
A4.世界のin vitro毒性試験市場の将来は、製薬産業、化粧品・家庭用品、学術機関・研究所、診断、化学産業、食品産業での機会が有望です。
Q5.市場の主要企業は?
A5.主なin vitro毒性試験市場企業は以下の通りですです。
Q6.今後、最大となる市場セグメントは?
A6.Lucintelは、予測期間中、全身毒性学が最大のセグメントであり続けると予測しています。
Q7.市場において、今後5年間に最大になると予想される地域は?
A7.北米は、治療研究に対する政府資金の増加、ヘルスケア支出の増加、洗練されたインフラと創薬手順の研究開発、承認に向けた強固な規制環境のため、予測期間中も最大地域であり続ける。
Q8.レポートのカスタマイズは可能?
A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。
In-Vitro Toxicology Testing Trends and Forecast
The future of the global in-vitro toxicology testing market looks promising with opportunities in the pharmaceutical industry, cosmetics & household product, academic institutes & research laboratories, diagnostic, chemicals industry, and food industry. The global in-vitro toxicology testing market is expected to reach an estimated $18.8 billion by 2030 with a CAGR of 9.3% from 2024 to 2030. The major drivers for this market are increasing attention to in vitro techniques for customized medicine and drug discovery, growing public opposition to animal experimentation, and work on early-stage toxicity detection through research and development.
A more than 150-page report is developed to help in your business decisions.
In-Vitro Toxicology Testing by Segment
The study includes a forecast for the global in-vitro toxicology testing by method, technology, application, end use, and region.
List of In-Vitro Toxicology Testing Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies in-vitro toxicology testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-vitro toxicology testing companies profiled in this report include-
In-Vitro Toxicology Testing Market Insights
Lucintel forecasts that systemic toxicology will remain the largest segment over the forecast period.
North America will remain the largest region over the forecast period due to the rise in government funding for therapeutic research, the rise in healthcare spending, the development of sophisticated infrastructure and drug discovery procedures, and the robust regulatory environment for approval.
Features of the Global In-Vitro Toxicology Testing Market
Market Size Estimates: In-vitro toxicology testing market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: In-vitro toxicology testing market size by various segments, such as by method, technology, application, end use, and region in terms of value ($B).
Regional Analysis: In-vitro toxicology testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different method, technology, application, end use, and regions for the in-vitro toxicology testing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the in-vitro toxicology testing market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the in-vitro toxicology testing market size?
Answer: The global in-vitro toxicology testing market is expected to reach an estimated $18.8 billion by 2030.
Q2. What is the growth forecast for in-vitro toxicology testing market?
Answer: The global in-vitro toxicology testing market is expected to grow with a CAGR of 9.3% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the in-vitro toxicology testing market?
Answer: The major drivers for this market are increasing attention to in vitro techniques for customized medicine and drug discovery, growing public opposition to animal experimentation, and work on early-stage toxicity detection through research and development.
Q4. What are the major segments for in-vitro toxicology testing market?
Answer: The future of the global in-vitro toxicology testing market looks promising with opportunities in the pharmaceutical industry, cosmetics & household product, academic institutes & research laboratories, diagnostic, chemicals industry, and food industry.
Q5. Who are the key in-vitro toxicology testing market companies?
Answer: The major drivers for this market are increasing attention to in vitro techniques for customized medicine and drug discovery, growing public opposition to animal experimentation, and work on early-stage toxicity detection through research and development.
Q6. Which in-vitro toxicology testing market segment will be the largest in future?
Answer: Lucintel forecasts that systemic toxicology will remain the largest segment over the forecast period.
Q7. In in-vitro toxicology testing market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the rise in government funding for therapeutic research, the rise in healthcare spending, the development of sophisticated infrastructure and drug discovery procedures, and the robust regulatory environment for approval.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.